LINDA VANDUYS: Open Payments
NPI 1134100159 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 65 payments from 16 companies in 2025. Trend: 2023 $1,965 · 2024 $2,010 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $325 |
| E.R. Squibb & Sons, L.L.C. | 14 | $173 |
| Philips North America LLC | 5 | $127 |
| PFIZER INC. | 5 | $103 |
| Alnylam Pharmaceuticals Inc. | 4 | $99 |
| Amgen Inc. | 4 | $70 |
| Esperion Therapeutics, Inc. | 3 | $54 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Abbott Laboratories | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
Products named: LEQVIO, Event, CAMZYOS, ONPATTRO, VYNDAQEL, ELIQUIS, Repatha, NEXLETOL.
Industry payments across SC — which companies pay providers there.
